Adenoid Cystic Carcinoma, from the CureRays guide library.

Adenoid cystic carcinoma is a slow-growing but persistent cancer of the salivary and other secretory glands that has a striking tendency to creep along nerves; treatment combines surgery with radiation — often using precise photon, neutron, or proton beams — to control the microscopic disease that travels beyond the visible tumor.

What it is.

Adenoid cystic carcinoma (ACC) is an uncommon cancer that arises in secretory glands — most often the salivary glands of the head and neck, but also the tear glands, the windpipe, the breast, and glands in the skin and elsewhere. It is known for a particular combination of traits: it usually grows slowly, yet it is relentless, with a strong tendency to come back over many years and to spread to distant organs, especially the lungs, sometimes a decade or more after the original treatment. Its most distinctive feature is perineural invasion — the cancer's habit of tracking along the sheaths of nerves, creeping outward from the visible tumor in a way that is invisible to the naked eye and easy to underestimate. This is why ACC can cause symptoms such as pain, numbness, or facial weakness out of proportion to the size of the lump, and why treatment must account for disease extending well beyond what can be seen or felt. Because the cancer follows nerves and infiltrates surrounding tissue, surgery alone often leaves microscopic disease behind, so radiation is a standard partner — given after surgery to treat the wider zone, including the paths of nearby nerves, and used as the main treatment when a tumor cannot be removed. ACC is relatively resistant to ordinary chemotherapy, so for many years particle-beam radiation (using neutrons or protons) has been studied as a way to deliver a more powerful or more precise dose, and the cornerstone of care remains the careful combination of complete surgery with radiation, followed by long-term monitoring.

How radiation treats it.

Radiation therapy treats adenoid cystic carcinoma by delivering precisely aimed beams of energy that damage the DNA inside tumor cells so they can no longer grow and divide. It is an essential partner to surgery in this cancer because of ACC's defining behavior: rather than staying within the visible tumor, it tracks along the sheaths of nerves and infiltrates surrounding tissue, leaving microscopic disease that extends well beyond what a surgeon can see or feel. If only the obvious tumor were removed, those extensions — particularly along nerves — could be left behind and seed a recurrence. Radiation treats a wider zone, deliberately including the paths of the nerves the cancer may be following, sterilizing that microscopic disease so the cancer is far less likely to return at the original site. This is why radiation after surgery is standard for most adenoid cystic carcinomas, even when the surgeon removes all visible tumor. When a tumor cannot be safely removed — for instance, when it is wrapped around critical nerves or sits near the eye or skull base — radiation becomes the main treatment. A particular challenge is that ACC is relatively resistant to ordinary radiation, which has driven the use of specialized particle beams. Neutron therapy is more biologically powerful than standard X-rays and has long been studied for inoperable salivary ACC; proton therapy deposits its dose at a precise depth and stops, allowing a high dose to the tumor while sparing the eye, optic nerves, and brain; and carbon-ion therapy combines precision with greater biological power against resistant tumors. The choice among these depends on the tumor's location, whether it was removed, and access to specialized centers. Modern photon techniques such as intensity-modulated radiation also shape the dose tightly around the target and the involved nerves while protecting nearby salivary tissue and the spinal cord. Radiation has a further role beyond the original site: because ACC tends to spread slowly to a limited number of lung deposits, focused stereotactic body radiation can ablate those spots without surgery.

The ways we can treat it.

Postoperative photon radiation (IMRT). Intensity-modulated photon radiation shapes the dose tightly around the tumor bed and the paths of involved nerves while sparing nearby structures such as the spinal cord, eyes, and salivary tissue.

Neutron therapy. Fast-neutron radiation is more biologically powerful than standard X-rays and has long been studied for adenoid cystic carcinoma, which resists ordinary radiation; it is delivered at a small number of specialized centers, especially for inoperable salivary tumors.

Proton therapy. Proton beams deposit their energy at a precise depth and stop, allowing a high dose to the tumor while sparing the eye, optic nerves, brain, and other critical structures — particularly valuable for tumors near the skull base or tear gland.

Carbon-ion therapy (selected centers). Carbon ions combine precise targeting with greater biological power against resistant tumors, and are used for selected adenoid cystic carcinomas at the few centers worldwide that offer them.

Stereotactic body radiation (SBRT) for metastases. Focused, high-dose radiation can ablate a limited number of lung deposits without surgery, fitting ACC's tendency to spread slowly to a few spots.

Questions we hear often.

Why does adenoid cystic carcinoma need radiation even when the surgeon removes the whole tumor? Because of its signature behavior: ACC tracks along the sheaths of nerves and infiltrates the surrounding tissue, leaving microscopic disease that extends well beyond the visible lump — often invisible at surgery. If only the obvious tumor is removed, those extensions, especially along nerves, can be left behind and cause the cancer to return. Radiation after surgery treats a wider zone, deliberately including the paths of nearby nerves, to sterilize that microscopic disease and greatly lower the chance of recurrence. This is why combined surgery and radiation is the standard approach for most adenoid cystic carcinomas, even when the operation appears complete.

Why is this cancer sometimes treated with neutrons or protons instead of ordinary radiation? Adenoid cystic carcinoma is relatively resistant to ordinary X-ray radiation, which has led to the use of specialized particle beams. Neutron therapy is more biologically powerful than standard radiation and has long been studied for salivary ACC that can't be removed. Proton therapy deposits its energy at a precise depth and then stops, which lets doctors give a high dose to the tumor while sparing nearby critical structures such as the eye, optic nerves, and brain — especially important for tumors near the tear gland or skull base. Carbon-ion therapy combines both advantages. These are offered at a limited number of specialized centers, and whether one is right depends on the tumor's location and whether it was removed.

Why do I need follow-up for so many years? Adenoid cystic carcinoma is unusual in how slowly and persistently it behaves. It can come back at the original site, or appear in the lungs, many years — sometimes a decade or more — after the first treatment. Because of this very long timeline, follow-up continues for a long period and usually includes periodic chest imaging, since the lungs are its favored site of spread. The advantage of this slow pace is that even when ACC does spread, it often grows gradually, so deposits caught while small can sometimes be controlled with focused radiation or other treatment, and long-term monitoring directly improves the chance of keeping the disease in check.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.